HOME >> MEDICINE >> NEWS
Study finds Latin American heart patients receive less treatment than North Americans and are nearly twice as likely to die

BARCELONA, Spain -- A new analysis of data gathered from an international drug study shows that patients in Latin America were treated with a more conservative approach and were nearly twice as likely to die within a month of being hospitalized for heart problems than were patients treated in North America.

The study also found that the Latin American patients received far fewer diagnostic procedures and only half as many angioplasties and cardiac bypass surgeries as did similar patients treated in the United States and Canada.

A team of international investigators, led by the Duke University Medical Center in Durham, N.C., prepared the findings for presentation at the annual meeting of the European Society of Cardiology.

Their analysis was done using information gathered on 585 patients treated at 72 hospitals in eight Latin American countries and 4,358 patients treated at 307 hospitals in the United States and Canada during a clinical trial called PURSUIT ("Platelet glycoprotein Iib/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy trial"). The study tested the use of Eptifibatide, a class of "super aspirin" drugs that help stop blood clots from forming. Patients were enrolled if they had chest pain or tests that indicated they were suffering from a heart attack or would probably soon have one.

"From what our study tells us, hospital physicians in Latin America take a much more conservative approach to treating patients with a heart attack than do doctors in North America, and this could be one of the factors associated with poorer patient survival," said the study's lead author, Dr. Mauricio Cohen, a cardiology fellow at the Duke Clinical Research Institute (DCRI).

He said that a "conservative" approach may reflect the way Latin American physicians are trained to treat heart patients. It is also possible that factors, not captured in the PURSUIT trial's data, such as less sophisticated hospital facilities and staffi
'"/>

Contact: Richard Merritt
merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
30-Aug-1999


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:5/18/2013)... who swallow high-powered magnets often need surgery and other ... new study. The researchers, from the Louisiana State ... than 79 percent of children who swallowed very strong ... in which a tube containing a camera is inserted ... cases can be treated through observation or by pumping ...
(Date:5/18/2013)... is associated with a reduced risk of primary ... Clinic research shows. The findings were being presented ... Orlando, Fla. , PSC is an inflammatory ... inflammation and subsequent fibrosis that can lead to ... cancer. , "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... New York, New York (PRWEB) May 18, 2013 ... Inc.’s Gynecare pelvic mesh products continue to move forward ... County Superior Court, Bernstein Liebhard LLP reports. According to ... Management Conference in the Ethicon pelvic mesh litigation will ... indicate that 2,755 complaints have been filed in the ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 TheBeautyPlace.com answers ... Pattern hair loss is not a result of stress, ... to Men’s Fitness Magazine, 70% of men suffer from ... Strength is renowned for hair transplant surgery, but ... male pattern baldness known as Bosley Professional Strength. Their ...
(Date:5/18/2013)... Philadelphia, PA (PRWEB) May 18, 2013 ... as indulging in healthy snacks and drinking more water ... weight loss and, ultimately, a healthier lifestyle overall. ... to achieve the best weight loss can be difficult ... treatments into their diet plans to help patients get ...
Breaking Medicine News(10 mins):Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies that ... that CEO Doug Godshall is scheduled ... 11:00 a.m. EDT on Monday, May 20, 2013.  The conference ... York Hotel. A live webcast of the Company,s ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
Cached News: